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http://dx.doi.org/10.1016/j.asjsur.20Summary Catamenial pneumothorax (CP) is a rare entity of spontaneous, recurring pneumo-
thorax in females. Although it has been known to be associated with thoracic endometriosis,
varying clinical course and the lack of consistent intraoperative findings have led to conflicting
etiological theories. We herein discuss the etiology, clinical course, and surgical treatment of
three patients with CP. Three females (aged 40 years, 28 years, and 34 years) had recurrent
right-sided spontaneous pneumothoraces that coincided with their menses. They had under-
gone video-assisted thoracoscopic surgery (VATS) previously. Blueberry spots in the right dia-
phragm were detected in all three cases. Two patients had recurrence, postoperatively. The
other patient, who received luteinizing hormone-releasing hormone analog therapy for an
abdominal endometriosis in the perioperative period and postoperative chemical pleurodesis
to prevent recurrence, has been free of recurrence for 15 months, postoperatively. However,
pelvic endometriosis was detected in this patient only. Therefore, CP should be suspected in
ovulating females with spontaneous pneumothorax, even in the absence of any symptoms asso-
ciated with pelvic endometriosis. In addition, while performing VATS, careful inspection of the
diaphragmatic surface is important. In complicated cases, hormonal suppression therapy and
chemical pleurodesis might also be helpful adjunct modalities.
Copyright ª 2013, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Chest Surgery, Kitakyushu
shaku, Kokurakita-ku, Kita-
-u.ac.jp (Y. Ichiki).
n Surgical Association. Published
13.09.0141. Introduction
Catamenial pneumothorax (CP) is a type of spontaneous
recurring pneumothorax that coincides with the menses in
females. The first report on CP was published in 1958,1 and
since then it has always been considered as a usualby Elsevier Taiwan LLC. All rights reserved.
Surgical treatment of catamenial pneumothorax 181condition for various reasons, especially due to its high
recurrence rate.2 In the past decade, the accuracy of
detecting CP has improved and subsequently more number
of cases are being reported, comprising almost one-third of
all spontaneous pneumothorax cases in females.3,4
The CP is generally considered to be the most frequent
presentation of thoracic endometriosis syndrome, although
histological findings of endometriosis during surgery are
rare.5 The etiology of CP is most likely to be multifactorial in
origin, involving a combination of different mechanisms.6e8
The optimal management of CP also remains unclear, as
the traditional treatments for pneumothorax are often
unsuccessful. The purpose of this study is to report three
typical cases of CP and to discuss the pathogenesis of CP.2. Case reports
We performed a retrospective review from January 2001 to
December 2011 of all female patients undergoing surgery
for spontaneous pneumothorax at the Kitakyushu Municipal
Medical Center (Fukuoka, Japan). Fourteen patients with
recurrent spontaneous pneumothorax received surgical
treatment. Of these, three (21.4%) were classified as having
CP. The diagnosis of CP was made based on preoperativeFigure 1 (A) Intraoperative findings of a perforation-like lesion
endometrial implant of the visceral pleura. Immunohistochemical a
(100). H&E Z hematoxylin and eosin.symptoms that coincided with their menses as well as on
the intraoperative pathological findings.2.1. Case 1
In December 2008, a healthy 40-year-old female had a
right-sided spontaneous pneumothorax and was treated
with a thoracic tube. Because of a recurrence after con-
servative treatment, video-assisted thoracoscopic surgery
(VATS) was performed. We noted a fenestration-like lesion
in the tendinous part of the diaphragm (Fig. 1A) and a
subpleural bulla in the apex of the right lung. A partial
resection of the diaphragm and a bullectomy were per-
formed. A histological examination of the resected tissues
confirmed an endometrial implant in the bulla, but not in
the diaphragm. The fenestration-like lesion had no fenes-
tration microscopically, and only some hemosiderin-laden
macrophages were observed. Immunohistochemical stain-
ing was positive for the estrogen receptor within the stroma
of the endometrial implant in the bulla (Fig. 1B). The pa-
tient had a recurrence that coincided with her menses in
February 2009. Chemical pleurodesis using OK432 was
performed twice after thoracic drainage. After recovery,
the patient has been symptom-free for 47 months.in the tendinous part of the diaphragm. (B) A focus of an
nalysis showed strong nuclear staining for the estrogen receptor
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In January 2009, a healthy 28-year-old female had a right-
sided spontaneous pneumothorax and was treated with a
thoracic tube. Because of recurrence after conservative
treatment, VATS was performed. We noted several blue-
berry spot-like lesions without fenestration in the tendi-
nous part of the diaphragm (Fig. 2A) and a whitish
subpleural change in the apex of the right lung. A partial
resection of the diaphragm and apical resection were per-
formed. The histological examination confirmed an endo-
metrial implant in the subpleural change, but not in the
diaphragm. The blueberry spot-like lesions had only some
hemosiderin-laden macrophages. Immunohistochemical
staining was positive for the estrogen receptor within the
stroma of the endometrial implant in the regions of sub-
pleural change (Fig. 2B). The patient had a recurrence that
coincided with her menses in March 2009. Chemical pleu-
rodesis using OK432 was performed once after the thoracic
drainage. After recovery, the patient has been symptom-
free for 35 months.
2.3. Case 3
In June 2011, a 34-year-old female receiving luteinizing
hormone-releasing hormone analog therapy for abdominal
endometriosis had a right-sided spontaneous pneumothorax
and was treated with a thoracic tube. Because of recur-
rence after conservative treatment, VATS was performed.
We noted several blueberry spots without fenestration inFigure 2 (A) Intraoperative findings of blueberry spot-like lesio
endometrial implant of the visceral pleura. Immunohistochemical a
(100). H&E Z hematoxylin and eosin.the tendinous part of the diaphragm (Fig. 3A) and a whitish
subpleural change and atelectasis in the middle lobe of the
right lung. A partial resection of the diaphragm and the
middle lobe was performed. A histological examination
confirmed an endometrial implant, where stromal cells
constantly admixed with extravasated erythrocytes, and
hemosiderin-laden macrophages were observed in the dia-
phragm without fenestration, but not in the region of sub-
pleural change. Immunohistochemical staining was positive
for the estrogen receptor within the stroma of the endo-
metrial implant in the diaphragm (Fig. 3B). Postoperatively,
chemical pleurodesis using OK432 was performed once to
prevent recurrence. After recovery, the luteinizing
hormone-releasing hormone analog therapy was continued,
and the patient has been symptom-free for 15 months.
The characteristics of the three patients are presented
in Table 1. There were no complications associated with
these treatments. The mean duration of thoracic tube
drainage was 3.3 days (range: 2e4 days). Hormonal treat-
ment was performed in only one patient, who had already
been receiving luteinizing hormone-releasing hormone
analog therapy prior to the surgery. Pelvic endometriosis
was also detected only in this patient. The others received
a gynecological evaluation postoperatively, but pelvic
endometriosis was not detected.
3. Discussion
The CP involves females of reproductive age and occurs
within 72 hours from the onset of menses. The right side isns in the tendinous part of the diaphragm. (B) A focus of an
nalysis showed strong nuclear staining for the estrogen receptor
Figure 3 (A) The intraoperative findings of diaphragmatic endometriosis. (B) A focus of an endometrial implant in the tendinous
part of the diaphragm. Immunohistochemical analysis showed strong nuclear staining for the estrogen receptor (100).
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in a recurrent manner.5,9 Several hypotheses about the
pathogenesis of CP have been put forth, including the
following: (1) spontaneous rupture of blebs; (2) alveolar
rupture caused by prostaglandin-induced bronchiolar
constriction; (3) fenestration of endometrial implants of
visceral pleura with subsequent air leakage; and (4) in the
absence of the cervical mucus plug, passage of air from the
genital tract through congenital or acquired diaphragmatic
defects. Thus, it is classically thought that CP is a typical
presentation of thoracic endometriosis.5,9 By contrast, CP
can also occur in the presence of diaphragmatic or thoracic
endometriosis.10
Endometriosis seems to play the most important role in
the development of CP, although an association with pel-
vic endometriosis has been reported in 20e70% of pa-
tients.4 In our experience, one of three patients with CP
had pelvic endometriosis. It seems that diaphragmatic
defects are strictly correlated with endometriosis. Dia-
phragmatic defects have been detected in 29e66% of CP
patients.4,7 In a previous study, Marshall et al11 reportedTable 1 Clinical details of patients.
Case Age
(y)
Pelvic
endometriosis
Pathological findings Surgic
treatm
1 40 No Visceral pleural implant ED, PL
2 28 No Visceral pleural implant ED, PL
3 34 Yes Diaphragmatic implant ED, PL
ED Z excision of diaphragm; P Z pleurodesis; PL Z partial lung reseconcomitant diaphragmatic defects and endometrial im-
plants, but the association was not widely observed. In our
case series, one patient had histological diaphragmatic
implantation.
The exact pathogenesis of thoracic endometriosis re-
mains controversial. The coelomic metaplasia theory has
been favored for many years; however, it cannot explain
the possible intrapulmonary localization of the disease or
its right-side predominance.5,12 Another theory has sug-
gested that the pathogenesis results from the trans-
plantation of endometrium to ectopic sites after lymphatic
or vascular embolization or retrograde menstruation.5,12
This last mechanism could explain the known right-sided
predominance of the disease, which was confirmed in our
experience. It is well-known that there exists a preferential
flow of peritoneal fluids and endometrial tissue from the
pelvis along the right paracolic gutter up to the subphrenic
space.10 Furthermore, the anatomy of the two upper
abdominal quadrants is different. The large, solid, and
compressible viscera of the left upper quadrant cannot
exert such activity.10al
ent
Chest tube
drainage (d)
Hormonal
treatment
Recurrence Follow-up
(mo)
2 No Yes 47
2 No Yes 35
, P 4 Yes No 15
ction.
184 Y. Ichiki et al.The surgical standard treatment for CP also remains
controversial. Although some studies have reported that
pleural abrasion alone is necessary for the management of
CP,5 others have reported that apical blebs and paren-
chymal implants should be resected, and diaphragmatic
fenestration should be excised or closed.13 Moreover,
because of the high recurrence rate, it was reported that
an additional procedure to specifically address the risk of
basilar recurrence on the diaphragm should be per-
formed.14,15 A polyglactin mesh placed on the diaphragm
appears to augment pleurodesis in this difficult area.7
Another option is pleurodesis using OK432 or talc, as we
used in Case 3. Although we have so far experienced no
recurrence in our patient who underwent postoperative
chemical pleurodesis, it is unclear whether the potential
risks of pleurodesis outweigh the benefits in this young
population. There were endometrial implants in the lungs
in Cases 2 and 3. Their resection margins were 2 cm or
more, which we regarded as sufficient. Although we could
not find any residual endometrial implants macroscopically,
we could not explain the causes of their recurrences.
Further studies including a large number of patients with a
longer follow-up time are thus needed.
It is therefore important to block the hormonal support
from the ovary to the existing endometrial tissue, and to
prevent further seeding, as part of the treatment. The
literature contains a variety of reports on the use of oral
contraceptives, progestational drugs, danazol, and
gonadotropin-releasing hormone (GnRH) agonists, although
controlled trials on the efficacy of these drugs in patients
with CP are still lacking.5,16e23 As no specific drug has so far
been shown to be superior to the others, the decision on
which to use is influenced by the costs, side effects,
duration of treatment, and the patient’s wish to become
pregnant.5 That said, the experience in the past two de-
cades has been the greatest with danazol and GnRH ago-
nists. Among the various medical options available, GnRH
agonists have been found to be the most effective in pre-
venting CP recurrence when given for prolonged periods of
up to 1 year.22,24,25 However, according to our experience,
we treated only one patient with both estro-
geneprogesterone treatment and postoperative pleurod-
esis, and to date she has not demonstrated recurrence.
The endometrial foci of both the stroma and glands in
different proportions were often with ecstatic glands and
mostly lined by pseudostratified cuboidal to cylindrical
epithelial cells. Immunohistochemically, most glands
showed cytoplasmic positivity, with broad-spectrum cyto-
keratin, cytokeratin 7, and BER-ER4 staining, as well as
strong nuclear staining for estrogen and progesterone re-
ceptors.26 In all of our cases, the stromal cells in the
endometrial implants showed intense nuclear staining for
the estrogen receptor. Therefore, while it seems to be
difficult to diagnose CP in a histological examination using
only hematoxylin and eosin staining, it is thought that
immunochemical staining for estrogen receptor is effective
to confirm the presence of endometrial implantation,
because it is often difficult to detect a lesion
macroscopically.
In conclusion, when a young female presents with
pneumothorax during menses, CP should be suspected, and
a careful investigation needs to be carried out to achieve acorrect diagnosis. At the time of surgery, the diaphragm
should be carefully inspected for any defects and endo-
metrial implantation: all defects should be corrected and
all nodules should be resected. Pleurodesis may be helpful
to avoid a recurrence in patients with CP. Hormonal
treatment also seems to be effective for enhancing the
surgical results.References
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